Apoya, Renato S.

HRN: 25-70-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/13/2024
08/20/2024
IV
2.25g
Q6h
Diabetic Foot Right
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: